Recent studies reveal that breast cancer-derived cathepsin C (CTSC) activates neutrophil membrane protease 3 (PR3), triggering Interleukin-1β (IL-1β)/nuclear factor-kB (NF-κB) signaling cascades through pro-IL-1β cleavage. Here, IL1B is linked to breast cancer.